DrugBank expands coverage to offer better service to customers globally
Category: # |   By Pankaj Singh |   Date: 2021-05-31

DrugBank expands coverage to offer better service to customers globally

DrugBank, an online database containing information on drugs and drug targets, has reportedly expanded its reach to provide improved service to global customers.

Malaysia, Colombia, Thailand, Austria, Indonesia, Italy, and Turkey are the seven new regions added to its product portfolio. Customers can now access new drug datasets for drug products and drug indications that are specific to each new location, in addition to DrugBank's already existing coverage, sources cited.

Mike Wilson, CEO of DrugBank, mentioned that the new additions make their pharmaceutical knowledge base making it more accessible and comprehensive. It gives new customers easier access to the product offerings while also assisting existing clients in expanding into new markets, he added.

The rest of DrugBank’s organized clinical data is accessible for clinical software clients, like those in the electronic medical records industry, through their local region. Those operating in various areas can use a single API to get clinical data from any combination of regions. Customers throughout the world can now search and store up-to-date medications with more accuracy and speed.

Trusted sources stated that customers who provide sophisticated clinical decision support can now use DrugBank's rich datasets for data analysis and insight generation thanks to the enhanced coverage. For such users, DrugBank solves a vital first step by normalizing multi-region pharmaceutical data by mapping them to common identifiers and updating these mappings regularly.

Craig Knox, CTO at DrugBank, expressed they experienced an increasing number of customers that require not only a drug lookup tool but also complicated data analysis to obtain insights and make predictions to enhance health outcomes.

DrugBank's structured datasets ultimately save them time by allowing customers to avoid an often-time-consuming phase, extract more value from their existing data, and gain insights faster, he added.

DrugBank has been providing various products that allow healthcare organizations to enhance healthcare delivery, as well as reveal insights into drug discovery. With the latest updates to its database, it has solidified itself as one of the leading providers of pharmaceutical knowledge.

Source Credit-

http://www.globenewswire.com/news-release/2021/05/31/2238589/0/en/Pharmaceutical-Knowledge-Database-DrugBank-Expands-Coverage-To-Thailand.html

 

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh     Twitter

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with Read more...

More News By Pankaj Singh

Shaurrya Teleservices & Airwaive team up to expand 5G network in India

Shaurrya Teleservices & Airwaive team up to expand 5G network in India

By Pankaj Singh

Airwaive and Shaurrya Teleservices (STS) has reportedly announced an international strategic collaboration to jointly build 5G wireless network service in India, assisting telecom providers in advancing 5G technology throughout the nation. Notably...

Valneva looking to capitalize on growing prevalence of Lyme disease

Valneva looking to capitalize on growing prevalence of Lyme disease

By Pankaj Singh

French drugmaker Valneva SE is now reportedly betting on its vaccine VLA15 for treating climate change-induced Lyme disease, as it looks to capitalize on growing prevalence of tick-borne illnesses following the disappointing sales of its COVID-19 vac...

Reliance Jio becomes the largest buyer of India’s USD 19 Bn 5G sale

Reliance Jio becomes the largest buyer of India’s USD 19 Bn 5G sale

By Pankaj Singh

Reliance Jio Infocomm Ltd., owned by billionaire industrialist Mukesh Ambani, was found to be the most aggressive participant in the government-backed 5G auction in India where several telecom behemoths agreed to invest at least USD 19 billion. Jio w...